Retained insulin benefits for good health
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study looks at whether keeping some natural insulin production helps people with diabetes stay healthier. It may help researchers understand the benefits of having some of your own insulin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have a diabetes diagnosis and use insulin (if you were in the StartRight study)
- You have type 1 diabetes, and either have a known C-peptide level or are within 7 years of diagnosis with a positive islet antibody test
- If your C-peptide is above 600 pmol/L, you must also have previous positive islet antibodies
- You do not have severe kidney failure (eGFR below 30)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medicine called anti-thymocyte globulin (h-ATG) to see if it can help people with type 1 diabetes keep making some of their own insulin. It may slow the loss of insulin-making cells and help manage blood sugar.
This study is looking for people with type 1 diabetes to better understand the condition and how it may be managed. You might qualify if you were diagnosed by a specialist and are insulin-dependent under certain conditions.
This trial tests an oral medication that may help your body respond better to insulin. It's for people with type 1 diabetes who use an automated insulin pump and are willing to take a daily pill for 12 weeks.
This study follows people of all ages who have a positive islet autoantibody test but no diabetes symptoms yet. It aims to track them over time to learn more about how type 1 diabetes develops, which may lead to better prevention and care.
This study enrolls people with islet autoantibodies, which are early markers for type 1 diabetes. It aims to understand who develops these antibodies and how they are linked to diabetes over time. No treatment is given—you just provide blood samples and answer questions.
This Phase 1/2 study tests whether CELZ-201 is safe and can help the body keep making some of its own insulin in people who were recently diagnosed with type 1 diabetes. You may be eligible if your diabetes started within the past year and your tests show you still have some insulin-making activity.
Hear when a new Diabetes (Insulin-requiring, Type 1 or Type 2) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.